To include your compound in the COVID-19 Resource Center, submit it here.

CARsgen paves way to IPO with $60M pre-C round

Immuno-oncology company CARsgen Therapeutics Co. Ltd. (Shanghai, China) is raising $60 million

Read the full 124 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE